MRI/CT Imaging Agent for Alzheimer's

About Alzeca Biosciences

Alzeca Biosciences is a private, early-stage diagnostics company targeting the massive and growing unmet need in Alzheimer's Disease detection. Its core innovation is the development of advanced contrast agents for MRI and CT scans, which could allow for the identification of disease pathology years before cognitive symptoms appear, at a lower cost and with greater global accessibility than current PET-based methods. The company is led by an experienced management team with deep expertise in diagnostic imaging and is supported by private investors and grants from organizations like the Cure Alzheimer's Fund and NIH.

Therapeutic Areas

Other Alzheimer's Disease Drugs